BAYRAK, S. Et Al. 2024. Lactoperoxidase Inhibition of Celecoxib Derivatives Containing the Pyrazole Linked-Sulfonamide Moiety: Antioxidant Capacity, Antimicrobial Activity, and Molecular Docking Studies. Journal of Biochemical and Molecular Toxicology , vol.38, no.11 .

BAYRAK, S., Gerni, S., Öztürk, C., Almaz, Z., Bayrak, Ç., Kılınç, N., ... ÖZDEMİR, H.(2024). Lactoperoxidase Inhibition of Celecoxib Derivatives Containing the Pyrazole Linked-Sulfonamide Moiety: Antioxidant Capacity, Antimicrobial Activity, and Molecular Docking Studies. Journal of Biochemical and Molecular Toxicology , vol.38, no.11.

BAYRAK, SONGÜL Et Al. "Lactoperoxidase Inhibition of Celecoxib Derivatives Containing the Pyrazole Linked-Sulfonamide Moiety: Antioxidant Capacity, Antimicrobial Activity, and Molecular Docking Studies," Journal of Biochemical and Molecular Toxicology , vol.38, no.11, 2024

BAYRAK, SONGÜL Et Al. "Lactoperoxidase Inhibition of Celecoxib Derivatives Containing the Pyrazole Linked-Sulfonamide Moiety: Antioxidant Capacity, Antimicrobial Activity, and Molecular Docking Studies." Journal of Biochemical and Molecular Toxicology , vol.38, no.11, 2024

BAYRAK, S. Et Al. (2024) . "Lactoperoxidase Inhibition of Celecoxib Derivatives Containing the Pyrazole Linked-Sulfonamide Moiety: Antioxidant Capacity, Antimicrobial Activity, and Molecular Docking Studies." Journal of Biochemical and Molecular Toxicology , vol.38, no.11.

@article{article, author={SONGÜL BAYRAK Et Al. }, title={Lactoperoxidase Inhibition of Celecoxib Derivatives Containing the Pyrazole Linked-Sulfonamide Moiety: Antioxidant Capacity, Antimicrobial Activity, and Molecular Docking Studies}, journal={Journal of Biochemical and Molecular Toxicology}, year=2024}